GID BIO Completes Enrollment for Cell Therapy Study
GID BIO completed enrollment for the first of two pivotal Phase III studies to investigate the use of your own...
GID BIO completed enrollment for the first of two pivotal Phase III studies to investigate the use of your own...
BONESUPPORT's CERAMENT G synthetic bone graft substitute received FDA marketing clearance for use in open fractures....
FDA granted 510(k) marketing clearance in the intervertebral disc space for Amplify Synthetic Bone Graft Putty....
HydroPutty bone graft features hydrophilic carriers designed to absorb fluids such as bone marrow aspirate, blood or saline....
CERAMENT bone void filler is an injectable, moldable and drillable synthetic bone void filler comprising hydroxyapatite and calcium sulfate....
The magnesium-based bone subsitute is cleared for use in the intervertebral body disc space, including cervical, thoracic and lumbar fusion....
Theradaptive gained FDA approval for their IDE submission to enroll patients into OASIS, a global Phase I/II Feasibility study in...
The proposed indication is an enhanced bioadhesive for reduction, provisional fixation or void filling of peri-articular fractures or defects....
Comprising the TrabeculeX Bioactive Matrix and TrabeculeX Recovery App, the TrabeculeX Continuum is a technology-enabled bridge between orthobiologics and digital...
RENOVITE BMP-2 is being developed as an alternative to bone graft materials for interbody spinal fusion....
As a guest member you get access to more articles and webinars every month.
We’ll send a recovery link to your email.
Return to Homepage